Tristel (LON:TSTL) Reaches New 1-Year High – Here’s What Happened

Tristel plc (LON:TSTL) hit a new 52-week high during mid-day trading on Friday . The company traded as high as GBX 572.50 ($7.43) and last traded at GBX 372.50 ($4.84), with a volume of 149584 shares trading hands. The stock had previously closed at GBX 385 ($5.00).

Tristel Stock Performance

The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12. The firm has a 50 day moving average of GBX 419.88 and a 200-day moving average of GBX 443.81. The company has a market cap of £177.50 million, a P/E ratio of 2,961.54 and a beta of 0.23.

Tristel Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, November 28th will be issued a dividend of GBX 8.28 ($0.11) per share. The ex-dividend date is Thursday, November 28th. This represents a yield of 2.1%. This is a positive change from Tristel’s previous dividend of $5.24. Tristel’s dividend payout ratio is currently 10,000.00%.

Insider Buying and Selling at Tristel

In related news, insider Elizabeth Dixon sold 50,000 shares of the company’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.15), for a total transaction of £198,500 ($257,725.27). Insiders own 4.89% of the company’s stock.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.